← FDA DRUG APPROVALS
FDA ANDA · ANDA214256
CHLORPROMAZINE HYDROCHLORIDE
chlorpromazine
Sponsor: SUN PHARM
APPLICATION
ANDA214256
TYPE
ANDA
ORIGINAL APPROVAL
2020-10-26
LATEST ACTION
2020-10-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 100MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 25MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 200MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 50MG · TABLET · ORAL
CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 10MG · TABLET · ORAL
Approval history
2020-10-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.